Stiefel Laboratories

Stiefel Laboratories is an American dermatological pharmaceutical company, with its global headquarters in Research Triangle Park, North Carolina. It makes products such as Duac and Oilatum. Stiefel was acquired by GlaxoSmithKline at a price of $2.9 billion. The company was founded in 1847 by John David Stiefel, Ferdinand von Hebra and Paul Unna, who initially created medicated soaps.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Duac	Benzoyl peroxide, Clindamycin	2002-08-26	2024-2040	Acne vulgaris , Actinomycetales infections , Bacterial infections , Bacterial vaginosis , Bacteroides infections , Pneumocystis pneumonia , Staphylococcal infections , Streptococcal infections , Toxoplasmosis
Hydrocortisone	Hydrocortisone	1982-01-01	2032-2034	Adrenal insufficiency , Congenital adrenal hyperplasia , Contact dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Hemorrhoids , Inflammation , Leg dermatoses , Pruritus ani , Rheumatic diseases , Scalp dermatoses , Shock , Status asthmaticus , Ulcerative colitis
Scabene	Lindane	1982-01-01		Lice infestations , Scabies
Soriatane	Acitretin	1996-10-28		Psoriasis

Clinical Trials

No data